Investment
Participated alongside Tasly Capital in Betterway Medical's roughly RMB 100M B round.
佰特微
MAR 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
佰特微
Interview with Dongmai Net (动脉网) on 2026 biotech outlook
派特美生
Tang Dajie named a top 10 healthcare investor of 2025